J Korean Ophthalmol Soc > Volume 53(1); 2012 > Article
Journal of the Korean Ophthalmological Society 2012;53(1):76-86.
DOI: https://doi.org/10.3341/jkos.2012.53.1.76    Published online January 15, 2012.
Complications after Intravitreal Triamcinolone Acetonide Injection: Incidence and Risk Factors.
Haeng Ku Kang, Hee Seung Chin
Department of Ophthalmology, Inha University School of Medicine, Incheon, Korea. hschin@inha.ac.kr
유리체강내 트리암시놀론 아세토나이드 주사 합병증에 대한 다각적 고찰: 발생률 및 위험요소
강행구⋅진희승
Department of Ophthalmology, Inha University School of Medicine, Incheon, Korea
Abstract
PURPOSE
To reduce complications and provide proper management for better clinical outcomes in the treatment of macular edema through a large-scale analysis of the incidence and risk factors for complications of intravitreal triamcinolone injection. METHODS: The medical records of 490 eyes that received intravitreal triamcinolone (4.0 mg) injection for treatment of macular edema caused by various diseases were retrospectively reviewed, and relevant parameters were included in a multivariate regression model. RESULTS: Vitrectomized (p < 0.001) and pseudophakic (p = 0.054) eyes were less likely to exhibit an intraocular pressure increase, but glaucoma (p < 0.001) and young age (p = 0.073) were found to be significant risk factors for this complication. Vitrectomized eyes (p = 0.011), diabetic macular edema (p < 0.001), secondary ocular hypertension (p = 0.029) and old age (p = 0.059) were associated with cataract progression. Three consecutive case of sterile endophthalmitis, which differs from bacterial endophthalmitis in clinical course and prognosis, occurred during the same period. CONCLUSIONS: Risk factors and the incidence of complications after intravitreal triamcinolone injection should be evaluated through regular follow-up evaluation to ensure proper management and a better prognosis.
Key Words: Cataract progression;Complication;Intravitreal triamcinolone acetonide;Secondary ocular hypertension;Sterile endophthalmitis


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next